Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | jumonji domain containing protein | 0.004 | 0.0434 | 0.0658 |
Echinococcus granulosus | nuclear receptor subfamily 1 group D | 0.0195 | 0.6416 | 0.9729 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.1299 | 0.7321 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0035 | 0.0233 | 0.0354 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0094 | 0.2521 | 0.3823 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.0199 | 0.6595 | 1 |
Echinococcus multilocularis | nuclear receptor subfamily 1 group D | 0.0195 | 0.6416 | 0.9729 |
Brugia malayi | TAR-binding protein | 0.0062 | 0.1299 | 0.5155 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.014 | 0.4318 | 0.5 |
Brugia malayi | RNA binding protein | 0.0062 | 0.1299 | 0.5155 |
Loa Loa (eye worm) | TAR-binding protein | 0.0062 | 0.1299 | 1 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0094 | 0.2521 | 0.3823 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0187 | 0.144 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0035 | 0.0233 | 0.0354 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.1299 | 0.7321 |
Brugia malayi | jmjC domain containing protein | 0.0094 | 0.2521 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0035 | 0.0233 | 0.1313 |
Brugia malayi | jmjC domain containing protein | 0.0035 | 0.0233 | 0.0925 |
Schistosoma mansoni | jumonji domain containing protein | 0.0075 | 0.1775 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0062 | 0.1299 | 0.197 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0035 | 0.0233 | 0.1313 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0059 | 0.118 | 0.9079 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.0787 | 0.312 |
Echinococcus granulosus | tar DNA binding protein | 0.0062 | 0.1299 | 0.197 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.1299 | 0.7321 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0062 | 0.1299 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.0787 | 0.312 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.1299 | 0.7321 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.0187 | 0.0742 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.014 | 0.4318 | 0.5 |
Echinococcus multilocularis | jumonji domain containing protein | 0.004 | 0.0434 | 0.0658 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.0787 | 0.6053 |
Loa Loa (eye worm) | RNA binding protein | 0.0062 | 0.1299 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0062 | 0.1299 | 0.5155 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0035 | 0.0233 | 0.1794 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.1299 | 0.7321 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0187 | 0.1054 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.014 | 0.4318 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0787 | 0.6053 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.0199 | 0.6595 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0792 | 0.6092 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 0.06 mM | Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition measured after 20 mins by electrophoretic mobility shift assay | ChEMBL. | 23414143 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.